NorthCrest Asset Manangement’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
12,983
-324
-2% -$48.6K 0.05% 246
2026
Q1
$2.05M Sell
13,307
-5,815
-30% -$891K 0.06% 214
2025
Q4
$2.64M Sell
19,122
-892
-4% -$117K 0.06% 210
2025
Q3
$2.63M Buy
20,014
+1,734
+9% +$212K 0.06% 198
2025
Q2
$2.23M Sell
18,280
-275
-1% -$31K 0.06% 206
2025
Q1
$2.07M Sell
18,555
-1,263
-6% -$134K 0.06% 204
2024
Q4
$1.93M Sell
19,818
-37,716
-66% -$4.02M 0.06% 206
2024
Q3
$6.62M Buy
57,534
+381
+0.7% +$43.2K 0.2% 120
2024
Q2
$6.08M Sell
57,153
-143
-0.2% -$14.4K 0.2% 128
2024
Q1
$5.54M Buy
57,296
+3,004
+6% +$308K 0.19% 131
2023
Q4
$5.48M Buy
54,292
+424
+0.8% +$40.9K 0.21% 130
2023
Q3
$5.49M Sell
53,868
-368
-0.7% -$37.4K 0.22% 126
2023
Q2
$5.47M Sell
54,236
-97
-0.2% -$9.7K 0.22% 127
2023
Q1
$5M Buy
54,333
+49,721
+1,078% +$4.34M 0.21% 129
2022
Q4
$418K Sell
4,612
-14,830
-76% -$1.25M 0.02% 303
2022
Q3
$1.48M Sell
19,442
-269
-1% -$22.3K 0.08% 167
2022
Q2
$1.67M Buy
+19,711
New +$1.73M 0.09% 166
2022
Q1
Sell
-21,384
Closed -$1.87M 440
2021
Q4
$1.87M Buy
+21,384
New +$1.78M 0.1% 156

Other funds holding NVS

NorthCrest Asset Manangement's NVS Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Novartis (NVS) stake by 2.4% in Q2 2026, selling an estimated $48.6K and leaving 12,983 shares worth $2.01M. The position accounts for 0.05% of the portfolio, ranked #246.

NorthCrest Asset Manangement first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.62M in Q3 2024. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • NorthCrest Asset Manangement held 12,983 shares of Novartis worth $2.01M as of Q2 2026.
  • NorthCrest Asset Manangement sold 324 Novartis shares in Q2 2026, an estimated $48.6K.
  • Novartis made up 0.05% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #246 holding.
  • NorthCrest Asset Manangement first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
  • NorthCrest Asset Manangement's Novartis position peaked at $6.62M in Q3 2024.
  • 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.